Skip to main content
. Author manuscript; available in PMC: 2014 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Jun 26;272(2):299–305. doi: 10.1016/j.taap.2013.06.016

Table 2.

Summarized results of pathology for 18-month old male mice

Groups Rate of HCC or dysplasia (tumor early stage) Rate of inflammation (portal) Rate of inflammation (parenchymal) Rate of bile ductular proliferation Rate of necrosis
Wild Type (n=6) N/A N/A N/A N/A N/A
FXR Knockout (n=10) HCC (5/10), high grade dysplasia (5/10) portal inflammation (6/10): mild (2/10), moderate (1/10), or marked (3/10) parenchymal inflammaiton (3/10): mild (1/10) or marked (2/10) 2/10 3/10
SHP Transgenic (n=8) N/A N/A N/A N/A N/A
FXR Knockout/SHP Transgenic (n=9) HCC (5/9), high grade dysplasia (1/9), low grade dysplasia (3/9) portal inflammation (4/9): mild (2/9), moderate (1/9), or marked (1/9) N/A 1/9 1/9